Harvard Bioscience (HBIO) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.67 +8.10%
Financial Fact:
Income tax expense: 758K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income tax expense: 758K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $28.8 million versus the consensus estimate of $26.6 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
